BAYN.DE - Bayer Aktiengesellschaft

XETRA - XETRA Delayed Price. Currency in EUR
101.96
-0.78 (-0.76%)
At close: 5:35PM CEST
Stock chart is not supported by your current browser
Previous Close102.74
Open102.88
Bid0.00 x 28400
Ask0.00 x 2100
Day's Range101.68 - 103.74
52 Week Range88.81 - 123.90
Volume2,330,415
Avg. Volume2,719,931
Market Cap87.761B
Beta0.96
PE Ratio (TTM)12.34
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.80 (2.68%)
Ex-Dividend Date2018-05-28
1y Target EstN/A
  • Why Bayer Aktiengesellschaft (FRA:BAYN) May Not Be As Efficient As Its Industry
    Simply Wall St.7 hours ago

    Why Bayer Aktiengesellschaft (FRA:BAYN) May Not Be As Efficient As Its Industry

    Bayer Aktiengesellschaft (DB:BAYN) generated a below-average return on equity of 9.09% in the past 12 months, while its industry returned 11.81%. BAYN’s results could indicate a relatively inefficient operation toRead More...

  • Bloombergyesterday

    Covestro to Cut Its Teeth on Small M&A Before Unlocking Billions

    Covestro AG, the German chemical maker with roots dating back more than 150 years, is acting like a young upstart as it considers its first acquisitions after former parent Bayer AG completed cutting ties this month. Covestro wants to add polymer technology and broaden its coatings, adhesives and specialty-products offerings, said Patrick Thomas, who steps down as chief executive at the end of this month. The manufacturer will focus initially on bite-size deals rather than any large purchase to avoid excessive risk to its business, Chief Financial Officer Thomas Toepfer said.

  • Reuters2 days ago

    CCI clears Bayer's deal for Monsanto

    The Competition Commission of India (CCI) has approved the acquisition of U.S. seed major Monsanto Co by Bayer AG, in a decision that moves the $62.5 billion deal a step closer to the finish line. German conglomerate Bayer is preparing to close the takeover this quarter, giving it control of more than 25 percent of the world's seed and pesticides market. Both Bayer and Monsanto had subsidiaries in India, making it mandatory for them to receive clearance from the CCI.

  • Reuters2 days ago

    Indian regulator clears Bayer's deal for Monsanto

    India's antitrust regulator has approved the acquisition of U.S. seed major Monsanto Co by Bayer AG, in a decision that moves the $62.5 billion deal a step closer to the finish line. German conglomerate Bayer is preparing to close the takeover this quarter, giving it control of more than 25 percent of the world's seed and pesticides market. Both Bayer and Monsanto had subsidiaries in India, making it mandatory for them to receive clearance from the Competition Commission of India (CCI).

  • Reuters2 days ago

    India's antitrust regulator approves Bayer's acquisition of Monsanto

    India's antitrust regulator said on Tuesday it had approved the acquisition of U.S. seed major Monsanto Co by Bayer AG, in a decision that moves the mega deal a step closer toward the finish line. The acquisition had been approved "subject to compliance of certain modifications," the regulator said on Twitter, without elaborating. German conglomerate Bayer is preparing to close its $62.5 billion takeover of Monsanto this quarter, giving it control of more than 25 percent of the world's seed and pesticides market.

  • The Wall Street Journal7 days ago

    [$$] European Companies Report Slower Earnings Growth

    European companies are reporting slower earnings growth as currency headwinds and higher input costs squeeze profits. As of Monday, 58% of the 363 companies in the Stoxx Europe 600 that have reported quarterly results beat analysts’ earnings expectations, according to JPMorgan Chase & Co. Earnings per share are up 10% year-over-year, also a smaller advance than in the first quarter of 2017 when earnings per share rose 25%, according to JPMorgan.

  • Reuters8 days ago

    (OFFICIAL)-U.S. grain exporter Bartlett to merge with logistics firm

    Bartlett and Company, which says it is a top exporter of U.S. grain to Mexico, will merge with logistics provider Savage Companies, the firms said on Wednesday, in the latest round of consolidation to hit the struggling agriculture sector. Officials for Missouri-based Bartlett and Utah-based Savage declined to release financial terms of the deal, which they expect to close in August.

  • Why Bayer Aktiengesellschaft (BAYRY) Might Surprise This Earnings Season
    Zacks9 days ago

    Why Bayer Aktiengesellschaft (BAYRY) Might Surprise This Earnings Season

    Bayer Aktiengesellschaft (BAYRY) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

  • Reuters12 days ago

    Bayer CFO sees lower Monsanto synergies after divestments: Boersen-Zeitung

    Bayer's potential synergies from buying U.S. rival Monsanto will be lower than $1.5 billion because of anti-trust divestments, the German company's Chief Financial Officer told Germany's Boersen-Zeitung. The $1.5 billion savings targeted within three years are a "pro forma" synergy goal, which excluded the impact of divestments, Johannes Dietsch told the newspaper. "The basis for revenue synergies is now lower.

  • Bayer CFO sees lower Monsanto synergies after divestments: Boersen-Zeitung
    Reuters12 days ago

    Bayer CFO sees lower Monsanto synergies after divestments: Boersen-Zeitung

    Bayer's potential synergies from buying U.S. rival Monsanto will be lower than $1.5 billion because of anti-trust divestments, the German company's Chief Financial Officer told Germany's Boersen-Zeitung. The $1.5 billion savings targeted within three years are a "pro forma" synergy goal, which excluded the impact of divestments, Johannes Dietsch told the newspaper. "The basis for revenue synergies is now lower.

  • Does Bayer Aktiengesellschaft’s (FRA:BAYN) Debt Level Pose A Problem?
    Simply Wall St.14 days ago

    Does Bayer Aktiengesellschaft’s (FRA:BAYN) Debt Level Pose A Problem?

    Investors pursuing a solid, dependable stock investment can often be led to Bayer Aktiengesellschaft (DB:BAYN), a large-cap worth €87.17B. Risk-averse investors who are attracted to diversified streams of revenue andRead More...

  • How Regeneron’s Praluent and Dupixent Performed in 1Q18
    Market Realist15 days ago

    How Regeneron’s Praluent and Dupixent Performed in 1Q18

    In 1Q18, Regeneron Pharmaceuticals’ (REGN) Praluent reported revenue of $60 million compared to $36 million in 1Q17, which reflected a ~67% rise on a YoY (year-over-year) basis and a ~5% rise quarter-over-quarter.

  • Reuters17 days ago

    Monsanto names Santos crop science leader in Latin America

    Rodrigo Santos, South America chief at Monsanto Co, has been named head of crop science in the Latin America region, reporting to Chief Operating Officer Brett Begemann, the company said in a statement ...

  • Associated Press17 days ago

    Monsanto CEO and others to leave after Bayer takeover

    ST. LOUIS (AP) — Monsanto Chairman and CEO Hugh Grant will leave the company after it's acquired by Germany's Bayer AG.

  • Monsanto CEO Grant to make way for Bayer's Condon post-takeover
    Reuters17 days ago

    Monsanto CEO Grant to make way for Bayer's Condon post-takeover

    Grant became CEO in 2003 and will leave following the close of the deal, along with other senior executives including Chief Financial Officer Pierre Courduroux and Chief Technology Officer Robert Fraley, Monsanto said on Monday. German conglomerate Bayer is preparing to close its $62.5 billion takeover of Monsanto this quarter, giving it control of more than 25 percent of the world's seed and pesticides market.

  • Reuters17 days ago

    Monsanto CEO Grant to make way for Bayer's Condon post-takeover

    Monsanto Co's Chief Executive Officer Hugh Grant will step down when Bayer AG completes the takeover of the U.S. seeds company, making way for Bayer executive Liam Condon to lead the combined crop sciences business. Grant became CEO in 2003 and will leave following the close of the deal, along with other senior executives including Chief Financial Officer Pierre Courduroux and Chief Technology Officer Robert Fraley, Monsanto said on Monday.

  • The Wall Street Journal17 days ago

    [$$] Monsanto CEO to Leave After Sale to Bayer

    Mr. Grant has worked at Monsanto for 35 years and has served as chairman and CEO since 2003. and a number of other top executives, such as the company’s general counsel and chief technology officer, are also leaving after the deal is completed, Monsanto said Monday.

  • Face of GMOs at Monsanto to Step Down as Bayer Takeover Closes
    Bloomberg17 days ago

    Face of GMOs at Monsanto to Step Down as Bayer Takeover Closes

    It’s the end of an era at Monsanto Co. after executives including the seed giant’s scientific leader Robb Fraley announced plans to depart after the company’s takeover by Germany’s Bayer AG. Fraley will depart “shortly after closing” on the Bayer deal, following a transition period, Monsanto said Monday in a statement. The $66 billion takeover by Germany’s Bayer is expected to close during the current quarter.

  • Reuters17 days ago

    Monsanto says CEO Hugh Grant will step down after Bayer deal closes

    Monsanto Co said on Monday Chief Executive Officer Hugh Grant will step down after the seeds company completes a deal to be acquired by Bayer AG. German conglomerate Bayer is preparing to close its $62.5 ...

  • MarketWatch17 days ago

    Monsanto CEO Hugh Grant says he will step down once the Bayer deal closes

    Monsanto Co. Chief Executive Hugh Grant said Monday he will step down and leave the company once the company's takeover by Bayer AG has closed. Grant will remain as CEO and chairman until then, he said ...

  • Thomson Reuters StreetEvents17 days ago

    Edited Transcript of BAYN.DE earnings conference call or presentation 3-May-18 12:00pm GMT

    Q1 2018 Bayer AG Earnings Call

  • Reuters20 days ago

    Bayer sells further Covestro stake for 2.2 billion euros

    Pharmaceutical group Bayer has sold a further stake in plastics company Covestro for 2.2 billion euros ($2.64 billion), placing a holding of 14.2 percent via an accelerated bookbuilding process. Covestro was spun off from Bayer in 2015, and Bayer said this latest sale marks the start of the full separation from its former unit. Bayer, which is buying seed maker Monsanto, raised 1.8 billion euros ($2.15 billion) in January by selling a 10.4 percent stake in Covestro.

  • Bayer Boosts Finances With $2.6 Billion Covestro Stake Sale
    Bloomberg21 days ago

    Bayer Boosts Finances With $2.6 Billion Covestro Stake Sale

    Bayer AG sold its remaining stake in Covestro AG, raising 2.2 billion euros ($2.6 billion) as the German drugmaker closes in on the planned $66 billion purchase of genetically modified seeds supplier Monsanto Co. Bayer sold 28.8 million, or 14 percent, of Covestro’s shares for 75.50 euros each, the company said in a statement on Friday. The transaction began after markets closed on Thursday and was managed by Bank of America Corp. and JPMorgan Chase and Co.

  • Bayer (BAYRY) Misses Earnings and Revenue Estimates in Q1
    Zacks21 days ago

    Bayer (BAYRY) Misses Earnings and Revenue Estimates in Q1

    Bayer (BAYRY) misses first-quarter 2018 earnings and sales estimates.

  • White House Asked to Fight Opioids by Overriding Drug Patents
    Bloomberg21 days ago

    White House Asked to Fight Opioids by Overriding Drug Patents

    The city of Baltimore and a consumer group are asking the Trump administration to fight the opioid epidemic with a novel weapon: overriding U.S. patents on the overdose antidote naloxone. By overriding patents for easy-to-use naloxone treatments including Kaleo Inc.’s injectable Evzio and closely held Adapt Pharma Inc.’s Narcan nasal spray, the government could reduce the cost and increase availability of the antidote, Baltimore’s health department and the advocacy group Public Citizen said in a letter to the White House on Thursday.